Cited by 582Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis MechanismsInflammatory Biomarkers in Disease Prognosis

The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.

The Hypercoagulable State of Malignancy: Pathogenesis and Current Debate

Open access

Caine, Graham J, Stonelake, Paul S, Lip, Gregory Y H, Kehoe, Sean T·2002·Neoplasia

DOI 10.1038/sj.neo.7900263PMC PMC1550339

Open this paper in CoChat — free account

Abstract

A hypercoagulable or prothrombotic state of malignancy occurs due to the ability of tumor cells to activate the coagulation system. It has been estimated that hypercoagulation accounts for a significant percentage of mortality and morbidity in cancer patients. Prothrombotic factors in cancer include the ability of tumor cells to produce and secrete procoagulant/fibrinolytic substances and inflammatory cytokines, and the physical interaction between tumor cell and blood (monocytes, platelets, neutrophils) or vascular cells. Other mechanisms of thrombus promotion in malignancy include nonspecific factors such as the generation of acute phase reactants and necrosis (i.e., inflammation), abnormal protein metabolism (i.e., paraproteinemia), and hemodynamic compromise (i.e., stasis). In addition, anticancer therapy (i.e., surgery/chemotherapy/hormone therapy) may significantly increase the risk of thromboembolic events by similar mechanisms, e.g., procoagulant release, endothelial damage, or stimulation of tissue factor production by host cells. However, not all of the mechanisms for the production of a hypercoagulable state of cancer are entirely understood. In this review, we attempt to describe what is currently accepted about the pathophysiology of the hypercoagulable state of cancer. We also discuss whether or not to screen patients with idiopathic deep venous thrombosis for an underlying malignancy, and whether this would be beneficial to patients. It is hoped that a better understanding of these mechanisms will ultimately lead to the development of more targeted treatment to prevent thromboembolic complications in cancer patients. It is also hoped that antithrombotic strategies may also have a positive effect on the process of tumor growth and dissemination.

Integrity signals

Registry

Crossref · 10.1038/sj.neo.7900263

Cites

128 of 128 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Prevention of Venous Thromboembolism
Geerts, W. H., Heit, J. A., Clagett, G. P., Pineo, G. F., Colwell, C. W., Anderson, F. A., & Wheeler, H. B. (2001) · CHEST Journal · doi:10.1378/chest.119.1_suppl.132s · Cited by 4,368
Prognosis of Cancers Associated with Venous Thromboembolism
Sørensen, H. T., Mellemkjær, L., Olsen, J. H., & Baron, J. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432504 · Cited by 1,628
A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors
Fisher, B., Costantino, J., Redmond, C. K., POISSON, R., Bowman, D., Couture, J., Dimitrov, N. V., Wolmark, N., Wickerham, D. L., Fisher, E. R., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902233200802 · Cited by 1,466
Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.
Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Fiers, W. C., Cotran, R. S., & Gimbrone, M. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4533 · Cited by 1,059
Rates of Initial and Recurrent Thromboembolic Disease Among Patients with Malignancy Versus Those without Malignancy: Risk Analysis Using Medicare Claims Data
Levitan, N. I., Dowlati, A., Remick, S. C., Tahsildar, H. I., Sivinski, L. D., Beyth, R. J., & Rimm, A. A. (1999) · Medicine · doi:10.1097/00005792-199909000-00001 · Cited by 891
Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.
Clauss, M. A., Gerlach, M. L., Gerlach, H., Brett, J., Wang, F., Familletti, P. C., Pan, Y.-C. E., Olander, J. V., Connolly, D. T., & Stern, D. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.6.1535 · Cited by 831
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
Hull, R. D., Raskob, G. E., Pineo, G. F., Green, D., Trowbridge, A. A., Elliott, C. G., Lerner, R. G., Hall, J. H., Sparling, T. G., Brettell, H. R., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204093261502 · Cited by 689
Activation of blood coagulation in cancer: Trousseau's syndrome revisited
Rickles, F., & Edwards, R. (1983) · Blood · doi:10.1182/blood.v62.1.14.bloodjournal62114 · Cited by 680
Deep-Vein Thrombosis and the Incidence of Subsequent Symptomatic Cancer
Prandoni, P., Lensing, A. W. A., Buller, H. R., Cogo, A., Prins, M. H., Cattelan, A. M., Cuppini, S., Noventa, F., & ten Cate, J. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210153271604 · Cited by 671
Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of Cortisone
Folkman, J., Langer, R., Linhardt, R. J., Haudenschild, C. C., & Taylor, S. (1983) · Science · doi:10.1126/science.6192498 · Cited by 619
The Risk of a Diagnosis of Cancer after Primary Deep Venous Thrombosis or Pulmonary Embolism
Sørensen, H. T., Mellemkjær, L., Steffensen, F. H., Olsen, J. H., & Nielsen, G. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804233381701 · Cited by 618
Activation of blood coagulation in cancer: Trousseau's syndrome revisited
Rickles, F., & Edwards, R. (1983) · Blood · doi:10.1182/blood.v62.1.14.14 · Cited by 595
Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis
Prandoni, P., Carta, M., Cogo, A., Ruol, A., Vigo, M., Casara, D., Lensing, A. W. A., Buller, H. R., & ten Cate, J. W. (1992) · The Lancet · doi:10.1016/0140-6736(92)91054-c · Cited by 581
In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease
Contrino, J., Hair, G. A., Kreutzer, D. L., & Rickles, F. R. (1996) · Nature Medicine · doi:10.1038/nm0296-209 · Cited by 535
Venous thromboembolism and cancer
Baron, J. A., Gridley, G., Weiderpass, E., Nyrén, O., & Linet, M. S. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10018-6 · Cited by 512
Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer
Levine, M. N., Hirsh, J., Arnold, A., Gent, M., Levine, M. N., Arnold, A., Bramwell, V. H. C., Pritchard, K. I., Stewart, D., Warr, D. G., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90008-6 · Cited by 508
Phlegmasia alba dolens.
Trousseau, A. (1865) · Medical Entomology and Zoology · Cited by 502
Cultured human endothelial cells generate tissue factor in response to endotoxin.
Colucci, M., Balconi, G., Lorenzet, R., Pietra, A., Locati, D., Donati, M. B., & Semeraro, N. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110945 · Cited by 500
Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice.
Zhang, Y., Deng, Y., Luther, T., Müller, M., Ziegler, R., Waldherr, R., Stern, D., & Nawroth, P. P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117451 · Cited by 482
Deep vein thrombosis of the leg
Kakkar, V. V., Howe, C. T., Nicolaides, A. N., Renney, J. T. G., & Clarke, M. (1970) · The American Journal of Surgery · doi:10.1016/s0002-9610(70)80023-x · Cited by 475
The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast Cancer
Levine, M. N., Gent, M., Hirsh, J., Arnold, A., Goodyear, M. D. E., Hryniuk, W., & Pauw, S. D. (1988) · New England Journal of Medicine · doi:10.1056/nejm198802183180703 · Cited by 410
Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer.
Saphner, T. J., Tormey, D. C., & Gray, R. G. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.2.286 · Cited by 401
Structure and function of thrombomodulin: a natural anticoagulant
Dittman, W., & Majerus, P. (1990) · Blood · doi:10.1182/blood.v75.2.329.bloodjournal752329 · Cited by 383
Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture
Moore, K., Esmon, C., & Esmon, N. L. (1989) · Blood · doi:10.1182/blood.v73.1.159.159 · Cited by 336
Structure and function of thrombomodulin: a natural anticoagulant
Dittman, W., & Majerus, P. (1990) · Blood · doi:10.1182/blood.v75.2.329.329 · Cited by 328
Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate
Garbisa, S., Sartor, L., Biggin, S., Salvato, B., Benelli, R., & Albini, A. (2001) · Cancer · doi:10.1002/1097-0142(20010215)91:4 · Cited by 316
Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor
Abé, K., Shoji, M., Jiang, C., Bierhaus, A., Danave, I. R., Micko, C. J., Casper, K. A., Dillehay, D. L., Nawroth, P. P., & Rickles, F. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8663 · Cited by 311
Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis
Raz, A., & Lotan, R. (1987) · Cancer and Metastasis Reviews · doi:10.1007/bf00144274 · Cited by 299
Hemostatic alterations in cancer patients
Rickles, F. R., Levine, M. N., & Edwards, R. L. (1992) · Cancer and Metastasis Reviews · doi:10.1007/bf01307180 · Cited by 281
Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.
Pritchard, K. I., Paterson, A. H. G., Paul, N., Zee, B. C.-Y., Fine, S., & Pater, J. L. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2731 · Cited by 269
Pathophysiology of the Thrombophilic State in the Cancer Patient
Falanga, A., & Rickles, F. R. (1999) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-994919 · Cited by 249
Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer.
Shoji, M., Hancock, W. W., Abé, K., Micko, C. J., Casper, K. A., Baine, R. M., Wilcox, J. N., Danave, I. R., Dillehay, D. L., Matthews, E., et al. (1998) · Europe PMC (PubMed Central) · Cited by 248
PREVENTION OF FATAL POSTOPERATIVE PULMONARY EMBOLISM BY LOW DOSES OF HEPARIN *1An International Multicentre Trial
(1975) · The Lancet · doi:10.1016/s0140-6736(75)90494-8 · Cited by 242
Deep venous thrombosis and occult malignancy: an epidemiological study
Nordström, M., Lindblad, B., Anderson, H., Bergqvist, D., & Kjellström, T. (1994) · BMJ · doi:10.1136/bmj.308.6933.891 · Cited by 235
Vascular Permeability Factor, Fibrin, and the Pathogenesis of Tumor Stroma Formationa
Dvorak, H. F., Nagy, J. A., Berse, B., Brown, L. F., Yeo, K.-T., YEO, T., Dvořàk, A. M., Water, L. V. D., Sioussat, T. M., & Senger, D. R. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb51603.x · Cited by 229
The tissue factor pathway of blood coagulation.
Nemerson, Y. (1992) · PubMed · Cited by 223
The Impact of All-trans-Retinoic Acid on the Coagulopathy of Acute Promyelocytic Leukemia
Barbui, T., Finazzi, G., & Falanga, A. (1998) · Blood · doi:10.1182/blood.v91.9.3093 · Cited by 217
Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue
Falanga, A., & Gordon, S. G. (1985) · Biochemistry · doi:10.1021/bi00341a041 · Cited by 211
Vascular endothelial growth factor–stimulated endothelial cells promote adhesion and activation of platelets
Verheul, H. M. W., Jorna, A. S., Hoekman, K., Broxterman, H. J., Gebbink, M. F. B. G., & Pinedo, H. M. (2000) · Blood · doi:10.1182/blood.v96.13.4216 · Cited by 210
Effect of warfarin on survival in small cell carcinoma of the lung. Veterans Administration Study No. 75
Zacharski, L. R. (1981) · JAMA · doi:10.1001/jama.245.8.831 · Cited by 207
Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen
Goodnough, L. T., Saito, H., Manni, A., Jones, P. K., & Pearson, O. H. (1984) · Cancer · doi:10.1002/1097-0142(19841001)54:7 · Cited by 200
Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line.
Pearlstein, E., Salk, P. L., Yogeeswaran, G., & Karpatkin, S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.4336 · Cited by 192
A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.
Chahinian, A. P., PROPERT, K. J., Ware, J., Zimmer, B., Perry, M. C., Hirsh, V., Skarin, A. T., Kopel, S., Holland, J. F., & Comis, R. L. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.8.993 · Cited by 190
Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial.
(1975) · PubMed · Cited by 189
The Thrombophilic State Induced by Therapeutic Agents in the Cancer Patient
Lee, A. Y. Y., & Levine, M. N. (1999) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-994915 · Cited by 182
Tissue Factor in Health and Disease
Semeraro, N., & Colucci, M. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657625 · Cited by 182
VEGF induces hyperpermeability by a direct action on endothelial cells
Hippenstiel, S., Krüll, M., Ikemann, A., Risau, W., Clauss, M. A., & Suttorp, N. (1998) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1998.274.5.l678 · Cited by 181
Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin
Green, D., Hull, R., Brant, R., & Pineo, G. F. (1992) · The Lancet · doi:10.1016/0140-6736(92)92064-m · Cited by 164
The prethrombotic state in cancer.
Luzzatto, G., & Schafer, A. I. (1990) · PubMed · Cited by 163
Neutrophil Activation and Hemostatic Changes in Healthy Donors Receiving Granulocyte Colony-Stimulating Factor
Falanga, A., Marchetti, M., Evangelista, V., Manarini, S., Oldani, E., Giovanelli, S., Galbusera, M., Cerletti, C., & Barbui, T. (1999) · Blood · doi:10.1182/blood.v93.8.2506 · Cited by 158
Radiosurgery of acoustic neurinomas
Flíckinger, J. C., Lunsford, L. D., Coffey, R. J., Linskey, M. E., Bissonette, D. J., Maitz, A. H., & Kondziolka, D. S. (1991) · Cancer · doi:10.1002/1097-0142(19910115)67:2 · Cited by 149
Platelets and Cancer Metastasis: More Than an Epiphenomenon
Honn, K. V., Tang, D. G., & Chen, Y. Q. (1992) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1002578 · Cited by 147
Occult Cancer in Patients with Venous Thromboembolism: which Patients, which Cancers
Monréal, M., Llamazares, J. F., Perandreu, J., Urrútia, A., Sahuquillo, J. C., & Contel, E. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657740 · Cited by 146
Cancer and Thrombosis: from Phlegmasia Alba Dolens to Transgenic Mice
Donati, M. B. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642690 · Cited by 144
Role of Platelets, Thrombin, Integrin llb-llla, Fibronectin and Von Willebrand Factor on Tumor Adhesion in Vitro and Metastasis in Vivo
Nierodzik, M. L., Klepfish, A., & Karpatkin, S. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642691 · Cited by 143
HYPERCOAGULABILITY IN CANCER
Green, K. B., & Silverstein, R. L. (1996) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70349-x · Cited by 138
Importance of Findings on the Initial Evaluation for Cancer in Patients with Symptomatic Idiopathic Deep Venous Thrombosis
Cornuz, J., Pearson, S. D., Creager, M. A., Cook, E. F., & Goldman, L. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-10-199611150-00001 · Cited by 136
Tissue factor expression and angiogenesisin human prostate carcinoma
Abdulkadir, S. A., Carvalhal, G. F., Kaleem, Z., Kisiel, W., Humphrey, P. A., Catàlona, W. J., & Milbrandt, J. (2000) · Human Pathology · doi:10.1053/hp.2000.6547 · Cited by 130
Thrombotic Complications of Central Venous Catheters in Cancer Patients
Bona, R. (1999) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-994916 · Cited by 121
The Prevalence and Associated Variables of Deep Venous Thrombosis in Patients with Advanced Cancer
Johnson, M. J., Sproule, M., & Paul, J. (1999) · Clinical Oncology · doi:10.1053/clon.1999.9023 · Cited by 116
Cellular Receptors in the Regulation of Plasmin Generation
Hajjar, K. A. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642693 · Cited by 116
Cancer Procoagulant and Tissue Factor Are Differently Modulated by All-trans-Retinoic Acid in Acute Promyelocytic Leukemia Cells
Falanga, A., Consonni, R., Marchetti, M., Locatelli, G., Garattini, E., Gambacorti-Passerini, C. B., Gordon, S. G., & Barbui, T. (1998) · Blood · doi:10.1182/blood.v92.1.143.413k18_143_151 · Cited by 115
Cancer procoagulant in human tumor cells: evidence from melanoma patients.
Donati, M. B., Gambacorti-Passerini, C. B., Casali, B., Falanga, A., Vannotti, P., Fossati, G., Semeraro, N., & Gordon, S. G. (1986) · PubMed · Cited by 113
Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study.
Clahsen, P. C., van de Velde, C. J., Julien, J. P., Floiras, J. L., & Mignolet, F. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.6.1266 · Cited by 112
Characterization of the platelet-aggregating activity of tumor cells.
Hara, Y., Steiner, M., & BALDINI, M. G. (1980) · PubMed · Cited by 110
All‐trans‐RETINOIC ACID INCREASES ADHESION TO ENDOTHELIUM OF THE HUMAN PROMYELOCYTIC LEUKAEMIA CELL LINE NB4
Marchetti, M., Falanga, A., Giovanelli, S., Oldani, E., & Barbui, T. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.4911029.x · Cited by 107
Prevention of Thrombotic Disorders in Cancer Patients Undergoing Chemotherapy
Levine, M. N. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657515 · Cited by 103
Fibrin activation of vascular endothelial cells. Induction of IL-8 expression
Qi, J., & Kreutzer, D. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.2.867 · Cited by 99
The incidence of occult cancer in patients with deep venous thrombosis: a prospective study
Bastounis, E., Karayiannakis, A. J., Makri, G. G., Alexiou, D., & Papalambros, E. L. (1996) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1996.426000.x · Cited by 96
Prevention of Post-operative Deep Leg Vein Thrombosis in Patients with Cancer
Gallus, A. S. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657514 · Cited by 91
Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor
Blann, A. D., Gurney, D. A., Wadley, M., Bareford, D., Stonelake, P. S., & Lip, G. Y. H. (2001) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200101000-00007 · Cited by 89
Self-citation
Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues
Lorenzet, R., Péri, G., Locati, D., Allavena, P., Colucci, M., Semeraro, N., Mantovani, A., & Donati, M. B. (1983) · Blood · doi:10.1182/blood.v62.2.271.271 · Cited by 88
Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: A cancer and leukemia group B study
Wall, J. G., Weiss, R. B., Norton, L., Perloff, M., Rice, M. A., Korzun, A. H., & Wood, W. C. (1989) · The American Journal of Medicine · doi:10.1016/s0002-9343(89)80604-7 · Cited by 85
Prevention of Venous Thromboembolism in Cancer Patients
Kakkar, A. K., & Williamson, R. C. N. (1999) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-994925 · Cited by 82
Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery
Falanga, A., Ofosu, F. A., Cortelazzo, S., Delaini, F., Consonni, R., Caccia, R., Longatti, S., Maran, D., Rodeghiero, F., Pogliani, E., et al. (1993) · British Journal of Haematology · doi:10.1111/j.1365-2141.1993.tb03218.x · Cited by 82
Venous thromboses of upper limbs are more frequently associated with occult cancer as compared with those of lower limbs
Girolami, A., Prandoni, P., Zanon, E., Bagatella, P., & Girolami, B. (1999) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199912000-00001 · Cited by 81
Mechanisms of Hypercoagulation in Malignancy and during Chemotherapy
Falanga, A. (1998) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022405 · Cited by 79
Occult cancer in patients with bilateral deep-vein thrombosis
Rance, A., Emmerich, J., Guedj, C., Fiessinger, J., & Emmerich, J. (1997) · The Lancet · doi:10.1016/s0140-6736(05)64210-9 · Cited by 78
Fibrinolysis and Cancer
Kwaan, H. C., & Keer, H. N. (1990) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1002674 · Cited by 73
Antithrombotic Strategies in Patients with Cancer
Prandoni, P. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657517 · Cited by 72
Venous Thromboembolism in Malignancy and Malignancy in Venous Thromboembolism
Rickles, F. R., & Levine, M. N. (1998) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022404 · Cited by 71
Occurrence of fibrin and tissue factor antigen in human small cell carcinoma of the lung.
Zacharski, L. R., Schned, A. R., & Sorenson, G. D. (1983) · PubMed · Cited by 71
Thrombosis in Cancer Patients Treated with Hematopoietic Growth Factors - A Meta-Analysis
Barbul, T., Finazzi, G., Grassi, A., & Marchioli, R. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650276 · Cited by 70
Human Tumor Procoagulants: Registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society on Thrombosis and Haemostasis
Edwards, R. L., Silver, J., Rickles, F. R., & Subcommittee), (. T. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651580 · Cited by 70
Thrombotic Complications of Central Venous Catheters in Cancer Patients
Monreal, M., & Davant, E. (2001) · Acta Haematologica · doi:10.1159/000046591 · Cited by 64
Guidelines for Clotting Studies in Cancer Patients
Falanga, A., Barbui, T., Rickles, F. R., & Levine, M. N. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649619 · Cited by 63
Platelets in tumor metastasis: generation of adenosine diphosphate by tumor cells is specific but unrelated to metastatic potential
Grignani, G., & Jamieson, G. (1988) · Blood · doi:10.1182/blood.v71.4.844.844 · Cited by 63
New Insights into the Pathogenesis of Coagulation Dysfunction in Acute Promyelocytic Leukemia
Tallman, M. S., Hakimian, D., Kwaan, H. C., & Rickles, F. R. (1993) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199309054728 · Cited by 60
An enzyme-linked immunosorbent assay for cancer procoagulant and its potential as a new tumor marker.
Gordon, S. G., & Cross, B. (1990) · PubMed · Cited by 55
Cancer Procoagulant in Acute Non Lymphoid Leukemia: Relationship of Enzyme Detection to Disease Activity
Donati, M. B., Falanga, A., Consonni, R., Alessio, M. G., Bassan, R., Buelli, M., Borin, L. M., Catani, L., Pogliani, E., Gugliotta, L., et al. (1990) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1647145 · Cited by 55
Cysteine proteinase procoagulant from amnion-chorion
Sg, G., Hasiba, U., Cross, B. A., Poole, M., & Falanga, A. (1985) · Blood · doi:10.1182/blood.v66.6.1261.1261 · Cited by 55
B-chronic lymphocytic leukemia. Prognostic implication of bone marrow histology in 120 patients experience from a single hematology unit
Pangalis, G. A., Roussou, P. A., Kittas, C. N., Kokkinou, S., & Fessas, P. (1987) · Cancer · doi:10.1002/1097-0142(19870215)59:4 · Cited by 54
All-trans-retinoic acid counteracts endothelial cell procoagulant activity induced by a human promyelocytic leukemia-derived cell line (NB4)
Falanga, A., Marchetti, M., Giovanelli, S., & Barbui, T. (1996) · Blood · doi:10.1182/blood.v87.2.613.bloodjournal872613 · Cited by 52
Telomerase activity in cervical cancer is quantitatively distinct from that in its precursor lesions
Kyo, S., Takakura, M., Tanaka, M., Kanaya, T., & Inoue, M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980220)79:1 · Cited by 51
Cancer Cell Procoagulants and Their Role in Malignant Disease
Gordon, S. J. G. (1992) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1002580 · Cited by 51
Platelet-cancer cell interaction in metastasis formation: a possible therapeutic approcach to metastasis prophylaxis.
Gastpar, H. (1977) · PubMed · Cited by 51
Production of an active urokinase by leukemia cells: A novel distinction from cell lines of solid tumors
Stephens, R. W., Alitalo, R., Tapiovaara, H., & Vaheri, A. I. (1988) · Leukemia Research · doi:10.1016/0145-2126(88)90061-6 · Cited by 50
The hypercoagulable state in cancer patients
Falanga, A., Ofosu, F. A., Delaini, F., Oldani, E., Dewar, L., Lui, L. C., & Barbui, T. (1994) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199401000-00004 · Cited by 49
Human breast and colon carcinomas express cysteine proteinase activities with pro‐aggregating and pro‐coagulant properties
Grignani, G., Falanga, A., Pacchiarini, L., Alessio, M. G., Zucchella, M., Fratino, P., & Donati, M. B. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910420414 · Cited by 48
Deep Vein Thrombosis as a Predictor of Cancer
Ahmed, Z., & Mohyuddin, Z. (1996) · Angiology · doi:10.1177/000331979604700307 · Cited by 46
PREVENTION OF VENOUS THROMBO‐EMBOLISM
Fletcher, J., Mclellan, D., Cade, J. F., Fisher, C., Gibbs, H. H., Stacey, M. C., & Vedig, A. E. (1999) · Australian and New Zealand Journal of Surgery · doi:10.1046/j.1440-1622.1999.01487.x · Cited by 46
Molecular Mechanisms Linking Thrombosis and Angiogenesis in Cancer
Shoji, M., Abé, K., Nawroth, P. P., & Rickles, F. R. (1997) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(96)00142-9 · Cited by 45
Beta‐thromboglobulin and platelet‐factor 4 in patients with cancer: Correlation with the stage of disease and the effect of chemotherapy
Al-Mondhiry, H. A. B. (1983) · American Journal of Hematology · doi:10.1002/ajh.2830140202 · Cited by 44
Warfarin Is Safe as Secondary Prophylaxis in Patients With Cancer and a Previous Episode of Venous Thrombosis
Bona, R., Hickey, A. D., & Wallace, D. M. (2000) · American Journal of Clinical Oncology · doi:10.1097/00000421-200002000-00020 · Cited by 41
8 Venous thromboembolism and cancer
Kakkar, A. K., Lorenzo, F., Pineo, G. F., & Williamson, R. C. (1998) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(98)80089-9 · Cited by 40
Cancer and Deep Venous Thrombosis
Monréal, M. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380020229035 · Cited by 39
Antithrombotic therapy in cancer
Kakkar, A. K., & Williamson, R. C. (1999) · BMJ · doi:10.1136/bmj.318.7198.1571 · Cited by 37
Analysis of serum cancer procoagulant activity and its possible use as a tumor marker
Gordon, S. G., & Benson, B. A. (1989) · Thrombosis Research · doi:10.1016/0049-3848(89)90256-9 · Cited by 36
Diagnostic Value of Fibrinopeptide A and Beta‐Thromboglobulin in Acute Deep Venous Thrombosis and Pulmonary Embolism
van Hulsteijn, H., Briët, E., Koch, C., Hermans, J., & Bertina, R. M. (1982) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1982.tb01956.x · Cited by 34
The site of activation of factor X by cancer procoagulant
Gordon, S. G., & Mourad, A. M. (1991) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199112000-00007 · Cited by 33
Procoagulant activity of mononuclear phagocytes from different anatomical sites in patients with gynecological malignancies
Semeraro, N., Montemurro, P., Conese, M., Giordano, P., Stella, M., Restaino, A., Cagnazzo, G., & Colucci, M. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910450208 · Cited by 32
Effects of dexamethasone on pro-inflammatory cytokine expression, cell growth and maturation during granulocytic differentiation of acute promyelocytic leukemia cells.
Gianni’, M., Norio, P., Terao, M., Falanga, A., Marchetti, M., Rambaldi, A., & Garattini, E. (1995) · PubMed · Cited by 28
Induction of monocyte-macrophage procoagulant activity by transformed cell lines.
Rambaldi, A., Alessio, G., Casali, B., Passerini, C. G., Donati, M. B., Mantovani, A., & Semeraro, N. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.10.3848 · Cited by 27
Three-stage chromogenic assay for the analysis of activation properties of factor X by cancer procoagulant
Mielicki, W. P., & Gordon, S. G. (1993) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199306000-00008 · Cited by 26
Alterations in platelet surface sialytransferase activity and platelet aggregation in a group of cancer patients with a high incidence of thrombosis.
Scialla, S. J., Speckart, S. F., Haut, M. J., & Kimball, D. B. (1979) · PubMed · Cited by 26
Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture
Moore, K., Esmon, C., & Esmon, N. L. (1989) · Blood · doi:10.1182/blood.v73.1.159.bloodjournal731159 · Cited by 24
Lack of association between venous thrombosis and subsequent malignancy in a retrospective cohort study in young patients
Subir�, M., Mateo, J., Souto, J. C., Alt�s, A., & Fontcuberta, J. (1999) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199903)60:3 · Cited by 22
“Idiopathic” Deep Venous Thrombosis: The Value of Routine Abdominal and Pelvic Computed Tomographic Scanning
Sannella, N. A., & O’Connor, D. J. (1991) · Annals of Vascular Surgery · doi:10.1007/bf02329376 · Cited by 22
Vascular endothelial growth factor–stimulated endothelial cells promote adhesion and activation of platelets
Verheul, H. M. W., Jorna, A. S., Hoekman, K., et al. (2000) · Blood · doi:10.1182/blood.v96.13.4216.h8004216_4216_4221 · Cited by 17
Evaluation of β thromboglobulin levels in cancer patients : Effects of antitumor chemotherapy
Jm, B., Ferrière, J.-P., Besse, G. H., Chollet, P. J. M., Gaillard, G., & Plagne, R. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90272-8 · Cited by 15
Plasma membrane vesicles as mediators of interactions between tumor cells and components of the hemostatic and immune systems.
Gj, G., & Gasic, T. B. (1982) · PubMed · Cited by 12
Anionic Dyes, Heparin, and Heparinoids: The Rediscovery of Polyanionic Tumor Inhibitors
Regelson, W. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1929 · Cited by 11
Cancer and deep venous thrombosis
Monreal, M. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.2.485 · Cited by 11
Expression of Plasminogen Activator as a Marker of Stimulation in Tumor-Associated Macrophages
Mussoni, L., & Donati, M. B. (2009) · Haemostasis · doi:10.1159/000215784 · Cited by 10
Heterogenous Mechanisms of Tumor Cell-Induced Platelet Aggregation with Possible Pharmacologic Strategy toward Prevention of Metastases
Karpatkin, S., & Pearlstein, E. (1984) · Springer eBooks · doi:10.1007/978-1-4613-3831-4_11 · Cited by 8
Mechanisms of Platelet Aggregation by Murine Tumor Cell Sheddings
Gasic, G., Gasic, T. B., & Stewart, G. J. (1984) · Springer eBooks · doi:10.1007/978-1-4613-3831-4_10 · Cited by 7
Alterations in platelet surface sialyltransferase activity and platelet aggregation in a group of cancer patients with a high incidence of thrombosis
Bingham, H. G. (1980) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-198001000-00101 · Cited by 6
Undiagnosed malignancy in patients with deep vein thrombosis: incidence, risk indicators, and diagnosis
(1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-0142(19980701)83:1 · Cited by 3

Sorted by citations

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Steffel, J., Verhamme, P., Potpara, T. S., Albaladejo, P., Antz, M., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy136 · Cited by 2,123
Self-citation
Tumors as Organs: Complex Tissues that Interface with the Entire Organism
Egeblad, M., Nakasone, E. S., & Werb, Z. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.05.012 · Cited by 1,294
American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer
Lyman, G. H., Khorana, A. A., Falanga, A., Clarke‐Pearson, D. L., Flowers, C. R., Jahanzeb, M., Kakkar, A. K., Kuderer, N. M., Levine, M. N., Liebman, H. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.1283 · Cited by 942
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation
Andrade, J. G., Aguilar, M., Atzema, C. L., Bell, A., Cairns, J. A., Cheung, C. C., Cox, J. L., Dorian, P., Gladstone, D. J., Healey, J. S., et al. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.09.001 · Cited by 593
Risk factors for chemotherapy‐associated venous thromboembolism in a prospective observational study
Khorana, A. A., Francis, C. W., Culakova, E., & Lyman, G. H. (2005) · Cancer · doi:10.1002/cncr.21496 · Cited by 564

See all 582

Authors: Caine, G. J., Stonelake, P. S., Lip, G. Y. H., & Kehoe, S. T.
Affiliations: Birmingham City Hospital (GB)
Birmingham Women's Hospital (GB)
ORCID: Lip, Gregory Y H
Kehoe, Sean T
Venue: Neoplasia
Publisher: Elsevier BV
Published: 2002
Volume: 4
Issue: 6
Pages: 465-473
ISSN: 1476-5586 (ISSN-L)
1522-8002
DOI: 10.1038/sj.neo.7900263
PMC: PMC1550339
OpenAlex: W2120304210
Cited by: 576
References: 125
Citations by year: 2026: 25 · 2025: 45 · 2024: 30 · 2023: 48 · 2022: 43 · 2021: 36 · 2020: 35 · 2019: 47 · 2018: 49 · 2017: 28 · 2016: 27 · 2015: 25 · 2014: 26 · 2013: 13 · 2012: 7
FWCI: 5.03
Type: journal article
Language: en
Open access: gold
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neoplasia (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Topics: Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
Keywords: cancer-associated thrombosis, hypercoagulability, procoagulant factors, fibrinolysis, inflammatory cytokines, tissue factor, antithrombotic therapy, venous thromboembolism
MeSH terms: Antineoplastic Agents, Blood Coagulation, Blood Coagulation Factors, Cell Communication, Humans, Neoplasms, Cytokines, Thrombophilia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Hypercoagulable State of Malignancy: Pathogenesis and Current Debate

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks